Global law firm Greenberg Traurig, LLP added four Corporate shareholders in its growing New York and Tel Aviv offices, all from McDermott.
Mark S. Selinger and Eyal Peled join as
Continue Reading Greenberg Traurig Adds Premier Israeli Corporate Team in New York and Tel Aviv
Global law firm Greenberg Traurig, P.A. was named “Patent Strategy Law Firm of the Year” by LMG Life Sciences EMEA (Europe, Middle East, and Africa). The recognition was announced
Continue Reading Greenberg Traurig Recognized as ‘Patent Strategy Firm of the Year’ by LMG Life Sciences EMEA
Continue Reading Join us: Raising Capital, M&A, SPACs and other Exits in the United States
Greenberg Traurig’s Tel Aviv office recently hosted an official delegation from Miami-Dade county as part of their visit to Israel.
The 60-person delegation, led by Hon. Daniella Levine- Cava, the
Continue Reading GT Tel Aviv Hosts Miami-Dade Delegation to Israel
Forty-three attorneys from global law firm Greenberg Traurig, LLP are recognized in the 2022 edition of the prestigious legal services directory Chambers Global. The global guide also recognizes the firm
Continue Reading Chambers Global 2022 Guide Recognizes Greenberg Traurig Attorneys, Practices
GT’s Tel Aviv Office has been recognized under seven Practice Areas by the 2021 edition of BDiCode.
BDiCode, one of Israel’s leading legal league tables has ranked our team of
Continue Reading GT Tel Aviv Ranked by BDiCode League Table
For the 3rd consecutive year, GT’s Tel Aviv office and members of the firm’s Israel Practice have been recognized by IsraelDesks‘ Legally Israel 100 directory.
Our Israel team
Continue Reading GT Recognized in 10 Practice Areas by Legally Israel 100 League Table
Congratulations to Memic Innovative Surgery (“Memic”), an Israeli medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, on completing a multimillion dollar Series D Financing Round.
Leading
Continue Reading GT Team Represents Medical Device Company in Series D Financing
Congratulations to our client Chemomab Therapeutics (“Chemomab”) on completing a merger with public company Anchiano Therapeutics. The combined company now goes by Chemomab Therapeutics Ltd. and is traded on Nasdaq
Continue Reading Congratulations to GT Client Chemomab on Recent Merger
Congratulations to our longstanding client, Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on
Continue Reading Congratulations to longstanding GT Client Enlivex on Completing Multi-Million Dollar Offering